Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
70,927.95
(
-2.94%
)
News Focus
News Focus
Post# of 257391
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122862
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: AlpineBV_Miller post# 54870

Friday, 11/16/2007 1:42:13 PM

Friday, November 16, 2007 1:42:13 PM

Post# of 257391
If some NSTK longs think PG is going to make a buyout bid, they’re badly mistaken, IMO.

PFE never dropped COLY’s cancer drug even though the phase-3 trials in NSCLC failed. PG, on the other hand, wants nothing whatsoever to do with NSTK’s intranasal PTH (or intranasal anything for that matter).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today